Filing Flows › Escalon Medical (ESMC) › Q4 FY26 › vs Q4 FY25
Escalon Medical (ESMC) Q4 FY26 vs Q4 FY25 (year over year)
Escalon Medical's revenue rose $1.3M (+50%) from $2.6M in Q4 FY25 to $3.9M in Q4 FY26. Operating margin 14.7% against -14.5% (+29.2 pts).
Escalon Medical, Q4 FY26: revenue $3.9M (+50% year over year), operating margin 14.7%, net earnings $1.8M, operating cash flow −$251K. The chart draws each line against Q4 FY25, the increases inside each band.
Margins
| Q4 FY26 | Q4 FY25 | Change | |
|---|---|---|---|
| Operating margin | 14.7% | -14.5% | +29.2 pts |
| Net margin | 46.1% | -14.8% | +60.9 pts |
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $3.9M | $2.6M | $1.3M | +50% |
| Other income, net | $73K | −$8K | $81K | — |
| Operating profit | $569K | −$372K | $940K | — |
| Costs & expenses | $3.3M | $2.9M | $351K | +12% |
| Pre-tax earnings | $642K | −$380K | $1.0M | — |
| Cost of revenue | $1.9M | $1.4M | $469K | +32% |
| Research & development | $124K | $292K | −$167K | -57% |
| SG&A | $1.3M | $1.2M | $49K | +4% |
| Income tax benefit | $1.1M | $0 | $1.1M | — |
| Net earnings | $1.8M | −$380K | $2.2M | — |
| Operating cash sources | $2.0M | −$387K | $2.4M | — |
| Depreciation & amortization | $3K | $9K | −$6K | -65% |
| Cash used in operations | $251K | −$16K | $267K | — |
| Working capital & other | $2.0M | −$387K | $2.4M | — |
Questions
How much did Escalon Medical's revenue grow year over year in Q4 FY26?
Escalon Medical's revenue rose $1.3M (+50%) from $2.6M in Q4 FY25 to $3.9M in Q4 FY26. Operating margin 14.7% against -14.5% (+29.2 pts).